Crossmark

Intravenous injection of human multilineage-differentiating stress-enduring cells alleviates mouse severe acute pancreatitis without immunosuppressants

Crossref DOI link: https://doi.org/10.1007/s00595-021-02382-7

Published Online: 2021-10-23

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fukase, Masahiko https://orcid.org/0000-0003-0819-149X
Sakata, Naoaki

Kushida, Yoshihiro

Wakao, Shohei

Unno, Michiaki

Dezawa, Mari
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (26293058)
License Information

Text and Data Mining valid from 2021-10-23

Version of Record valid from 2021-10-23
More Information

Article History

Received: 24 May 2021

Accepted: 16 July 2021

First Online: 23 October 2021

Declarations

:

: Mari Dezawa received research funding from Life Science Institute, Inc. (Tokyo, Japan). Mari Dezawa, Shohei Wakao, and Yoshihiro Kushida hold a patent for Muse cells and the isolation method thereof, licensed to Life Science Institute, Inc.

Document is current

Any future updates will be listed below